Laurel Wealth Advisors (North Carolina)’s Avanos Medical AVNS Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12	Closed	-$1K	–	656
2020 Q4	$1K	Hold	12	–	–	﹤0.01%	565
2020 Q3	$0	Hold	12	–	–	﹤0.01%	529
2020 Q2	$0	Hold	12	–	–	﹤0.01%	513
2020 Q1	$0	Hold	12	–	–	﹤0.01%	515
2019 Q4	$0	Hold	12	–	–	﹤0.01%	526
2019 Q3	$0	Hold	12	–	–	﹤0.01%	511
2019 Q2	$1K	Hold	12	–	–	﹤0.01%	494
2019 Q1	$1K	Hold	12	–	–	﹤0.01%	468
2018 Q4	$1K	Buy	+12	New	+$629	﹤0.01%	475

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s AVNS Position: Q1 2021 in Review

Laurel Wealth Advisors (North Carolina) sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 12 shares — an estimated $1K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in AVNS in Q4 2018 and held it in 9 quarters. The position peaked at $1K in Q4 2020. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

Laurel Wealth Advisors (North Carolina) reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
Laurel Wealth Advisors (North Carolina) sold 12 Avanos Medical shares in Q1 2021, an estimated $1K.
Laurel Wealth Advisors (North Carolina) first reported a position in Avanos Medical in Q4 2018 and held it in 9 quarters.
Laurel Wealth Advisors (North Carolina)'s Avanos Medical position peaked at $1K in Q4 2020.
291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2021, filed 4 May 2021.